BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

355 related articles for article (PubMed ID: 8050551)

  • 1. Effects of PAF, FMLP and opsonized zymosan on the release of ECP, elastase and superoxide from human granulocytes.
    Turner NC; Wood LJ; Foster M; Gueremy T
    Eur Respir J; 1994 May; 7(5):934-40. PubMed ID: 8050551
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differential effects of platelet-activating factor on superoxide anion production in human eosinophils and neutrophils.
    Mabuchi K; Sugiura T; Ojima-Uchiyama A; Masuzawa Y; Waku K
    Biochem Int; 1992 May; 26(6):1105-13. PubMed ID: 1321621
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of terfenadine on human eosinophil and neutrophil chemotactic response and generation of superoxide.
    Eda R; Townley RG; Hopp RJ
    Ann Allergy; 1994 Aug; 73(2):154-60. PubMed ID: 8067599
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibitory effects of formoterol on platelet-activating factor induced eosinophil chemotaxis and degranulation.
    Eda R; Sugiyama H; Hopp RJ; Okada C; Bewtra AK; Townley RG
    Int Arch Allergy Immunol; 1993; 102(4):391-8. PubMed ID: 8241801
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of lipoxin A4 on chemotaxis and degranulation of human eosinophils stimulated by platelet-activating factor and N-formyl-L-methionyl-L-leucyl-L-phenylalanine.
    Soyombo O; Spur BW; Lee TH
    Allergy; 1994 Apr; 49(4):230-4. PubMed ID: 8037356
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Beta-adrenergic stimulation down-regulates neutrophil priming for superoxide generation, but not elastase release.
    Barnett CC; Moore EE; Partrick DA; Silliman CC
    J Surg Res; 1997 Jul; 70(2):166-70. PubMed ID: 9245567
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Noncytotoxic activation of neutrophils by eosinophil granule major basic protein. Effect on superoxide anion generation and lysosomal enzyme release.
    Moy JN; Gleich GJ; Thomas LL
    J Immunol; 1990 Oct; 145(8):2626-32. PubMed ID: 2170521
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Regulation of the release of eosinophil cationic protein by eosinophil adhesion.
    Xu X; HÃ¥kansson L
    Clin Exp Allergy; 2000 Jun; 30(6):794-806. PubMed ID: 10848898
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Superoxide generation by guinea-pig peritoneal macrophages is inhibited by rolipram, staurosporine and mepacrine in an agonist-dependent manner.
    Turner NC; Wood LJ
    Cell Signal; 1994 Nov; 6(8):923-31. PubMed ID: 7718411
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Stimulation of degranulation from human eosinophils by platelet-activating factor.
    Kroegel C; Yukawa T; Dent G; Venge P; Chung KF; Barnes PJ
    J Immunol; 1989 May; 142(10):3518-26. PubMed ID: 2541198
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Investigation of the role of nitric oxide and cyclic GMP in both the activation and inhibition of human neutrophils.
    Wanikiat P; Woodward DF; Armstrong RA
    Br J Pharmacol; 1997 Nov; 122(6):1135-45. PubMed ID: 9401778
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibitory effect of pemirolast, a novel antiallergic drug, on leukotriene C4 and granule protein release from human eosinophils.
    Kawashima T; Iwamoto I; Nakagawa N; Tomioka H; Yoshida S
    Int Arch Allergy Immunol; 1994; 103(4):405-9. PubMed ID: 8130655
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Eosinophil leukocyte degranulation in response to serum-opsonized beads: C5a and platelet-activating factor enhance ECP release, with roles for protein kinases A and C.
    Egesten A; Malm J
    Allergy; 1998 Nov; 53(11):1066-73. PubMed ID: 9860239
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The influence of IL-3, IL-5, and GM-CSF on normal human eosinophil and neutrophil C3b-induced degranulation.
    Carlson M; Peterson C; Venge P
    Allergy; 1993 Aug; 48(6):437-42. PubMed ID: 8238799
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Platelet-activating factor primes human eosinophil generation of superoxide.
    Zoratti EM; Sedgwick JB; Bates ME; Vrtis RF; Geiger K; Busse WW
    Am J Respir Cell Mol Biol; 1992 Jan; 6(1):100-6. PubMed ID: 1309421
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of some anti-asthma drugs on human eosinophil superoxide anions release and degranulation.
    Ezeamuzie CI; Al-Hage M
    Int Arch Allergy Immunol; 1998 Feb; 115(2):162-8. PubMed ID: 9482706
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Platelet activating factor stimulates cyclo-oxygenase activity in guinea pig eosinophils. Concerted biosynthesis of thromboxane A2 and E-series prostaglandins.
    Giembycz MA; Kroegel C; Barnes PJ
    J Immunol; 1990 May; 144(9):3489-97. PubMed ID: 2158510
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Superoxide responses to formyl-methionyl-leucyl-phenylalanine in primed neutrophils. Role of intracellular and extracellular calcium.
    Walker BA; Hagenlocker BE; Ward PA
    J Immunol; 1991 May; 146(9):3124-31. PubMed ID: 1849943
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Eosinophil granulocyte interaction with serum-opsonized particles: binding and degranulation are enhanced by tumor necrosis factor alpha.
    Egesten A; Blom M; Calafat J; Janssen H; Knol EF
    Int Arch Allergy Immunol; 1998 Feb; 115(2):121-8. PubMed ID: 9482700
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition of cytoskeletal rearrangement by botulinum C2 toxin amplifies ligand-evoked lipid mediator generation in human neutrophils.
    Grimminger F; Sibelius U; Aktories K; Suttorp N; Seeger W
    Mol Pharmacol; 1991 Oct; 40(4):563-71. PubMed ID: 1656192
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.